Literature DB >> 14968363

Cell cycle and no end.

Mathewos Tessema1, Ulrich Lehmann, Hans Kreipe.   

Abstract

Our knowledge about the molecular circuits regulating the duplication of the genetic material and the subsequent division of a cell into two daughter cells has exploded over the last decade. Aberrations in the regulation of the cell cycle belong to the hallmarks of malignant transformation, leading, in turn, to the development of tumours. After introducing the basics of eukaryotic cell-cycle regulation and describing the four phases of the cell cycle (namely, G1, S, G2 and M) in more detail, alterations of key components of the cell-cycle machinery in human malignancies and their functional consequences are presented. Principally, deregulation of the cell cycle can be caused by unrestricted activity of cell-cycle promoting factors (many oncogenes fall into this class) or by inactivation of inhibitory factors (many tumour suppressor genes belong to this class). Both types of deregulation have been described in human tumours and are discussed in detail. Perspectives concerning the translation of this knowledge into daily routine practice and future applications are discussed at the end. The molecular mechanisms of actual cell division (sister chromatid segregation and cytokinesis) are mentioned only briefly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14968363     DOI: 10.1007/s00428-003-0971-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  110 in total

1.  Breast cancer genes and DNA repair.

Authors:  A R Venkitaraman
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

Review 2.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 3.  Cyclins and cell cycle checkpoints.

Authors:  D G Johnson; C L Walker
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

4.  Lack of p21(CIP1) DNA methylation in acute lymphocytic leukemia.

Authors:  LanLan Shen; Yutaka Kondo; Jean-Pierre Issa; Guillermo Garcia-Manero
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Predicting the future of breast cancer.

Authors:  Ake Borg; Mårten Fernö; Carsten Peterson
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

Review 6.  Cell cycle checkpoints: preventing an identity crisis.

Authors:  S J Elledge
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 7.  p16(MTS-1/CDKN2/INK4a) in cancer progression.

Authors:  J W Rocco; D Sidransky
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

8.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

Review 9.  Control of DNA replication licensing in a cell cycle.

Authors:  Hideo Nishitani; Zoi Lygerou
Journal:  Genes Cells       Date:  2002-06       Impact factor: 1.891

10.  C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer.

Authors:  Claus M Schlotter; Ulf Vogt; Ulrich Bosse; Berthold Mersch; Katja Wassmann
Journal:  Breast Cancer Res       Date:  2003-01-13       Impact factor: 6.466

View more
  7 in total

Review 1.  Global analysis of gene expression in mammalian kidney.

Authors:  Olga Soutourina; Lydie Cheval; Alain Doucet
Journal:  Pflugers Arch       Date:  2004-12-21       Impact factor: 3.657

2.  GINS2 regulates cell proliferation and apoptosis in human epithelial ovarian cancer.

Authors:  Ting Yan; Wentong Liang; Enli Jiang; Aizhu Ye; Qian Wu; Mingrong Xi
Journal:  Oncol Lett       Date:  2018-06-11       Impact factor: 2.967

3.  Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.

Authors:  Mollianne McGahren Murray; Tuyen Bui; Michelle Smith; Rozita Bagheri-Yarmand; Hannah Wingate; Kelly K Hunt; Khandan Keyomarsi
Journal:  Carcinogenesis       Date:  2013-05-30       Impact factor: 4.944

4.  The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.

Authors:  Lunxu Li; Shilin Xia; Xueying Shi; Xu Chen; Dong Shang
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

5.  The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251.

Authors:  Youxin Zhou; Zuopeng Su; Yulun Huang; Ting Sun; Sansong Chen; Tingfeng Wu; Guilin Chen; Xueshun Xie; Bin Li; Ziwei Du
Journal:  J Exp Clin Cancer Res       Date:  2011-12-20

6.  TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor.

Authors:  Reshma Sundar; Shyam Kumar Gudey; Carl-Henrik Heldin; Marene Landström
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Identification of G1-regulated genes in normally cycling human cells.

Authors:  Maroun J Beyrouthy; Karen E Alexander; Amy Baldwin; Michael L Whitfield; Hank W Bass; Dan McGee; Myra M Hurt
Journal:  PLoS One       Date:  2008-12-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.